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Chlamydia trachomatis is the world’s most prevalent bacterial sexually transmitted infection and leading infectious cause of
blindness, yet it is one of the least understood human pathogens, in part due to the difficulties of in vitro culturing and
the lack of available tools for genetic manipulation. Genome sequencing has reinvigorated this field, shedding light on
the contemporary history of this pathogen. Here, we analyze 563 full genomes, 455 of which are novel, to show that
the history of the species comprises two phases, and conclude that the currently circulating lineages are the result of evo-
lution in different genomic ecotypes. Temporal analysis indicates these lineages have recently expanded in the space of
thousands of years, rather than the millions of years as previously thought, a finding that dramatically changes our under-
standing of this pathogen’s history. Finally, at a time when almost every pathogen is becoming increasingly resistant to an-
timicrobials, we show that there is no evidence of circulating genomic resistance in C. trachomatis.
[Supplemental material is available for this article.]
Chlamydia trachomatis infections, including their severe sequelae,
are major public health concerns globally, resulting in significant
morbidity and health care costs (Owusu-Edusei et al. 2013). C.
trachomatis has been estimated to be the most common bacterial
sexually transmitted infection (STI) worldwide, with 131 million
cases among adults annually (World Health Organisation 2014;
Newman et al. 2015). Furthermore C. trachomatis is the etiological
agent of the severe ocular disease trachoma, with an estimated 232
million people at risk of blindness worldwide (World Health
Organisation 2014).
Our clinical and epidemiological understanding of C. tracho-
matis is primarily based upon typing of the ompA gene: genotypes
A, B, Ba, and C associate with trachoma (ocular lineage); D, E, F, G,
H, I, Ia, J, and Kwith urogenital infection (lineages T1 and T2); and
L1, L2, L2b, L2c, and L3with themore invasive lymphogranuloma
venereum (LGV) lineage (Harris et al. 2012). Biologically, despite
the large number of cases and the potential severity of infections,
C. trachomatis is poorly understood due to its obligate intracellular
lifestyle, the difficulties in growing strains in vitro, and, until re-
cently, a lack of genetic tools formanipulation and transformation
(Wang et al. 2011; Song et al. 2013).
Genomics has provided an alternative route to understanding
this disease and has shown thatC. trachomatishas evolved through
reductive evolution, likely from nonpathogenic ancestors that
became specialized to humans (Stephens et al. 1998; Borges et al.
2012). C. trachomatis comprises a ∼1-Mb chromosome and ∼7-kb
plasmid (Stephens et al. 1998). The species phylogeny consists of
four deeply branching lineages that are strongly, but not exclusive-
ly, associated with site of infection (Joseph et al. 2011; Borges et al.
2012; Harris et al. 2012; Andersson et al. 2016).
Homologous recombination, pervasive across the bacterial
kingdom (Feil et al. 2001), was initially thought to be uncommon
in C. trachomatis owing to its intracellular niche (Fraser et al. 2007;
Nunes et al. 2007). However, recent whole-genome analyses have
shown that recombination is widespread acrossmultiple species of
the Chlamydiaceaewith the ratio of diversity introduced by recom-
bination and mutation (r/m) estimated at between 0.56 and 3.19
(r/m 0.71–1.11 for C. trachomatis), and certain regions of the ge-
nome, including the clinically and epidemiologically relevant
ompA, exhibit elevated levels of fixed, and therefore detectable, re-
combinations (Brunelle and Sensabaugh 2005; Klint et al. 2007;
Joseph et al. 2011, 2012; Harris et al. 2012; Read et al. 2013). This
is backed up experimentally, with in vitro coinfections of several
C. trachomatis strains leading to extensive homologous recombina-
tion (Jeffrey et al. 2013), and supported by epidemiological esti-
mates of mixed infections at between 2% and 13% (DeMars et al.
2007). These studies indicate that recombination is possibly the
more important mechanism generating diversity in this species.
Antimicrobial resistance is currently recognized as one of the
most critical threats to human health. Many bacterial species
are becoming fully resistant to all frontline drugs, including
sexually transmitted bacteria such as Neisseria gonorrhoeae and
Mycoplasma genitalium, which commonly coinfect with C. tracho-
matis (Unemo and Shafer 2011). Despite treatment failures of
C. trachomatis infections with recommended therapeutic antimi-
crobials being reported (Hogan et al. 2004), isolated reports of
genomically conferred resistance (Misyurina et al. 2004; Jiang
et al. 2015), and the ease with which resistance can be selected
for in vitro by exposure to subinhibitory antimicrobial concentra-
tions (Sandoz and Rockey 2010), little is known about the preva-
lence, if any, of circulating resistance traits.
This studywasmotivated by the fact that our current genomic
view of C. trachomatis is based on whole-genome data sets of at
most 59 genomes, limited largely by sample collection technology
and sequencing cost. There remain many unanswered questions,
including the age of C. trachomatis, the rate of evolution, and the
evolutionary differences between and within the four deep-
branching lineages. The rate of single-nucleotide polymorphism
(SNP) accumulation is particularly important as estimating it
would allow us to better understand the dynamics of infection
transmission. In addition, there is a critical need to establish
whether antimicrobial resistance has begun to circulate in clinical
isolates. This study sought to elucidate, in a detailed manner, the
evolution of the C. trachomatis species by sequencing a worldwide
collection of hundreds of current and historical clinical strains, in-
creasing the sample size studied for this pathogen by nearly an or-
der of magnitude. This study forms the most comprehensive and
robust analysis of C. trachomatis genomics yet undertaken, in-
cludes cultured isolates as well as those sequenced directly from
primary clinical specimens, and provides clear insights into the
evolutionary history and dynamics, which may have implications
for diagnosis, epidemiology, and human public health worldwide.
Results
We present the largest and broadest genomic and evolutionary
study of C. trachomatis published to date, comprising 563 full ge-
nomes of isolates collected between 1957 and 2012, 455 of which
are reported here for the first time (Supplemental Table S1). We
strove to obtain samples without, or withminimal, laboratory pas-
sage in order to assemble a set of isolates representative of clinical
and in vivo evolution. Recent work examining the impact of in vi-
tro culture has shown that pseudogenization is directly associated
with prolonged laboratory passage, emphasizing the importance
of culture-free techniques to fully understand natural patterns of
evolution (Bonner et al. 2015). This entailed the use of culture-
free DNA extraction methods from primary diagnostic swab sam-
ples and direct-from-sample sequencing strategies developed by
us and others to complement the samples grown by minimal cul-
ture (Seth-Smith et al. 2013a; Christiansen et al. 2014). We
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obtained 76 genomes using multiple displacement amplification
(MDA), 103 with additional immunomagnetic separation (IMS-
MDA), and 77 samples by SureSelect target enrichment, providing
170 novel genomes obtained without the use of culture. Our sam-
pling included clinical samples from a diverse cross-section of
countries (n = 21) in Europe, North America, South America,
Africa, Asia, and Australia. All known genotypes are represented,
including isolates that do not fit the generally understood linkage
between genotype and site of infection. Historical archived
samples dating to the 1950s are also included. Together, this
data set provides a unique basis to answer subtle, but fundamental,
questions about the evolutionary flux in this important human
pathogen.
The species consists of four deep-branching lineages
The global phylogeny of all samples sequenced thus far (Fig. 1)
confirms that the species consists of four deep-branching mono-
phyletic lineages that generally associate with tropism—two uro-
genital lineages, T1 (n = 250) and T2 (n = 193); an ocular lineage
(n = 61); and a LGV lineage (n = 59)—consistent with previous re-
ports (Harris et al. 2012; Joseph et al. 2012; Nunes and Gomes
2014). Plasmid inheritance was almost entirely vertical at this res-
olution except for three cases where plasmid replacement from
other lineages has occurred (Supplemental Fig. S1); in addition,
the plasmid phylogeny associated with lineage T2 is paraphyletic
due to an apparent recombination event (Supplemental Fig. S2).
Geographical location is significantly associated with phylo-
genetic distance in the urogenital lineages (Fig. 2). This informa-
tion allows us to say that isolates fewer than 210 (T1) or 280 (T2)
SNPs apart are more than 50% likely to come from the same coun-
try, whereas for isolates to have a 50% probability of sharing the
same genotype, the distances are much larger: 1850 SNPs and
1470 SNPs for lineages T1 and T2, respectively. Genotype, as ex-
pected, is also significantly correlated with evolutionary distance
(Fig. 2) and, furthermore, is strongly associated with lineage
(Table 1). We see no association between the gender of the patient
and evolutionary separation of strain. Limited geographical sam-
pling in the ocular and LGV lineages prohibits us fromdrawing de-
finitive conclusions, although we note that all LGV isolates
were sampled from males due to current transmission patterns of
this clade. Culture-free isolates show phylogenetic clustering
most likely due to the nonrandom nature of sample collection
and processing. Importantly, we see both cultured and culture-
free extractionmethods providing samples that locate throughout
the tree, indicating that there is no sizeable diversitymissed by cul-
ture methods alone.
Of the 51 countries known or suspected to be endemic for tra-
choma (World Health Organisation 2014), we have samples from
only six. This limited range reflects the fact that most control pro-
grams do not routinely collect samples, so our sampling is largely
limited to the areas that have active research projects; therefore, we
are limited to analyzing small pockets of genetic variation for this
disease. A recent study investigating trachoma in the Aboriginal
Figure 1. Global phylogeny and recombination landscape of 563 C. trachomatis genomes. The phylogeny (left), with associated genotype and geo-
graphical data, is displayed alongside the linearized chromosome (right). Lineage labels are as per previous publications. Line graph (right, top) shows
the number of recombination events affecting individual genes and are colored according to lineage. Black blocks below this graph show previously iden-
tified “hotspots” of recombination (Harris et al. 2012). Colored blocks (right, bottom) indicate inferred recombination events each affecting selected taxa
and genomic location, with color indicating the number of inferred events. Gene annotations correspond to strain D/UW3. (PZ) Plasticity zone.
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population of Australia showed that isolates with genotypes B, Ba,
and C were found outside the ocular lineage and were associated
with ocular disease (Andersson et al. 2016), as indicated in
Supplemental Figure S3. Within this study, we find isolates with
the same genomic backbone, including genotype, as those from
Australia in urogenital samples from Europe (Supplemental Fig.
S3), indicating that these strains are not restricted to Australia.
Previous studies with relatively small sample sizes have al-
lowed identification of the broad differences between lineages
but have not been able to define evolutionary characteristics with-
in the lineages themselves. The phylogeny shown in Figure 1 elu-
cidates the contrasting appearance of the two urogenital lineages.
T1, in comparison with T2, contains fewer vertically inherited
SNPs as evidenced by its “flatter” appearance. T1, the most sam-
pled lineage in this study, contains a monophyletic expansion
consisting almost entirely of genotype E isolates (n = 148/149)
(Table 1). Genotype E is the most epidemiologically successful ge-
notypeworldwide and is entirely containedwithin this expansion,
indicating a relatively recent emergence where recombination has
not disrupted the ompA gene, yet one that has spread worldwide.
This contrasts with previous studies showing that ompA has the
highest rates of observed recombination, which results in frequent
genotype switching across the species (Harris et al. 2012).
A comparison of phylogenies with
and without predicted recombination
events (Supplemental Fig. S4) left the
overall structure of four lineages firmly
intact, indicating that recombination
events have not introduced sufficient
homoplasy to disrupt this evolutionary
signal. Recombinations have, however,
resulted in extensive intra-lineage chang-
es in topology, a discordance that indi-
cates that recombination must be taken
into account when trying to understand
the evolution of the species on detailed
level.
Lineage-specific patterns
of recombination
The evolutionary, clinical, and epidemi-
ological significance of recombination
in C. trachomatis has recently become ap-
parent, and we have investigated these
dynamics in much greater detail than
previously possible. By examining all
563 genomes in the present study, we
detected 1116 putative recombination
blocks (Fig. 1, heatmap) spanning an average of 7.5 kb per recom-
bination (95% CI: 7.0–8.0 kb) and covering an average of 246 kb
per isolate (23% of the genome) with an average r/m of 0.31.
Hotspots of recombination were originally observed around the
ompA locus (Gomes et al. 2006) and subsequently detected to be
nonuniformly distributed across the genome (Harris et al. 2012).
It is clear that with deeper sampling, the recombination landscape
is more dynamic than would be expected from a small number of
hotspots (Fig. 1). The six previously identified regions of higher
than average recombination (Harris et al. 2012) are identified
here, including region 1 (around ompA), region 2 (including
pmpE-I), region 3 (around CT051 and hemN), and region 6 (around
CT622). We find that regions 4 and 5 are bridged into one contin-
uous region of increased recombination that encompasses the
plasticity zone (PZ) (Fig. 1). While these regions show increased
rates of recombination in all lineages, the majority of recombina-
tion is specific to a lineage or a clade within a lineage, such as be-
tween regions 3 and 4 (spanning rl28 to CT103) that has markedly
increased recombination present only in lineage T1. Indeed, the
overall effect of recombination varies nearly 10-fold between line-
ages, from r/m = 0.37 (ocular) to 3.11 (T1) (Table 2). The two uro-
genital lineages also experience markedly differing amounts of
recombination (r/m 1.23–3.11), a result that leads to dramatic
Figure 2. Proportion of pairwise isolates sharing a given trait (country or genotype) as a function of
genomic divergence for the well-sampled urogenital lineages T1 (top) and T2 (bottom). (Top, left) For in-
stance any pair of isolates less than approximately 400mutations apart contain the same trait (country of
isolation) in 50% of cases. (Red) Observed data; (blue) 100 permutations; (left) country of isolation;
(right) genotype.
Table 1. Genotype distribution and prevalence across the lineages
A B-Ba C D E F G H I-Ia J K L1 L2 L2b L2C L3 Total
T1 0 3 5 22 148 68 0 0 0 4 0 0 0 0 0 0 250
T2 0 8 0 38 0 0 59 18 15 18 37 0 0 0 0 0 193
Ocular 53 6 2 0 0 0 0 0 0 0 0 0 0 0 0 0 61
LGV 0 0 0 0 0 0 0 0 0 0 0 20 11 26 1 1 59
Total 53 17 7 60 148 68 59 18 15 22 37 20 11 26 1 1 563
Gray shading indicates genotypes present in multiple lineages.
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differences in how recombination shapes their respective phylog-
enies (Table 1; Supplemental Fig. S4), further suggesting that T1 is a
more recent lineage that has experienced expansion driven by re-
combination. These observations are only made possible by larger
and more representative sampling and confirm that our previous
views were too simplistic. Variation in recombination across a ge-
nome may be mechanistic, selective, or stochastic. There is no ev-
idence for mechanistic differences (Gomes et al. 2006), and the
consistency of locations of recombination across samples refutes
a stochastic process, leading us to conclude that we are seeing
the signatures of selective pressures on multiple levels: the species
as a whole, a lineage, or an expansion within a lineage.
These lineage-specific evolutionary traits provide for the first
time important clues as to the roles of genes in different host envi-
ronments. To define the genes in these recombination regions that
are lineage specific, we clustered genes according to the number of
observed recombination events per lineage. This clustering (Fig. 3;
Supplemental Table S2) helps us to elucidate sets of genes under
differing selective pressures in different lineages. For example, we
found a set of 18 genes, including the inclusionmembrane protein
genes incA and incB, that appears to be under increased selective
pressure in the LGV clade. Inc genes are known immune targets,
and these results may indicate a selective host pressure specific
to this lineage. As in vitro experiments often use LGV strains (ow-
ing to their ease of infection in cell culture), these data should be
consulted to ensure that the genes of interest are not under differ-
ing dynamics in the LGV lineage alone.
Evolutionary timeline for the emergence of C. trachomatis
The temporal history and mutation rate of C. trachomatis is poorly
understood and has never been directly calculated. Root-to-tip
analysis shows that the LGV clade contains significant temporal
structure (R2 = 0.62, permuted P≤ 0.001) (Supplemental Fig. S5).
This clade contained a number of isolates dating to the 1960s, se-
quenced here from stocks archived in the 1960s. A Bayesian anal-
ysis of these isolates using BEAST (Drummond and Rambaut 2007)
placed the most recent common ancestor (MRCA) of the LGV
clade around 900 CE (common era) (95%highest posterior density
[HPD] 200 CE–1430 CE) (Fig. 4A; Supplemental Fig. S5). These re-
sults are dramatically different to a previous estimate of 15Myr ago
(Joseph et al. 2012), which used estimates of the split between C.
trachomatis andC. pneumoniae, rather than our historical sampling
approach. Our data predict that the L2b isolates arose about 100 yr
ago, which fits with epidemiological reports (Schachter and
Moncada 2005).
Our estimated substitution rates for this lineage were 2.15 ×
10−7 SNPs/site/year (95% HPD 1.03 × 10−7–3.33 × 10−7), i.e., 0.2
SNPs per genome per year, which is consistent with rates reported
for other bacteria, including the intracellular Buchnera aphidicola
(Fig. 4B). The recently published substitution rate for the closely re-
lated Chlamydia psittaci of 1.68 × 10−4 mutations/site/yr (∼175
SNPs/yr) (Read et al. 2013) is nearly three orders of magnitude fast-
er than that reported here and, when applied to these data, would
predict that all modern C. trachomatis strains share a common an-
cestor within the past century, which is not possible. Analysis of
other lineages showed some correlation between age and root-to-
tip distance; however, this was not significant and could be an ar-
tifact of population structure, unidentified recombination events,
or the scarcity of remaining vertically inherited SNPs. Long-term
laboratory passage results in very few adaptive mutations, indicat-
ing that this is not amajor source of bias (Borges et al. 2013).While
it is perhaps unwise to extend the results from the LGV lineage to
other lineages, doing so would indicate that all lineages are expan-
sions during a timescale measured in thousands or in tens of thou-
sands of years rather than in millions.
The origins of ompA
The ompA gene has strong relevance for clinical, epidemiological,
and public health understanding, despite recombining frequently
and at different rates compared with the rest of the genome. Our
results clarify the usefulness and limitations of using ompA for ep-
idemiology or phylogenetic inference. The majority of genotypes
(12/16) are restricted to single lineages, with a further two (D, J)
each found in both urogenital lineages (T1, T2) (Table 2). We
found classical ocular genotypes B/Ba and C segregating multiple
times in the urogenital lineages, consistent with previous reports
and once again underlining the danger of using genotyping as a
proxy for phylogenetic relatedness (Supplemental Fig. S3).
Importantly, some of these isolates, which have a urogenital back-
bone and ocular ompA genes, were associated both with urogenital
infections and ocular disease in children up to 9 yr of age, a finding
detailed by Andersson et al. (2016).We find European isolates that
are almost identical, including ompA type, showing that these
strains are not geographically isolated.
The gene ompA is associated with phylogeny and tropism, de-
spite experiencing thehighest rates of observable recombination in
the genome. TheC. trachomatis ompA gene phylogeny reveals three
clear lineages (labeled α, β, and γ) (Fig. 5A), which are broadly
inconsistent with both tropism and whole-genome phylogeny.
For instance, the “ocular” ompA types appear phylogenetically un-
related, while all LGV ompA types group together consistent with
the whole genome. Four variable regions provide the majority of
variation within the ompA gene with the regions at the 5′ and 3′
endsof the gene showing themost conservation (Fig. 5C), a pattern
that was conserved across all members of the genus studied and
may facilitate homologous recombination (Supplemental Fig. S6).
Comparison between major outer membrane protein (MOMP)–
encodinggenes inothermembersof theChlamydiaceae revealedev-
idence for between-species recombination in othermembers of the
genus,but theC. trachomatis ompA formsamonophylymost closely
Table 2. Recombination statistics
r/m LB UB r m n ILHR OLHR
All 0.312 41,152 131,920 563 — —
Ocular 0.366 0.308 0.415 1363 3722 61 0.21 0.93
LGV 0.605 0.509 0.762 1198 1981 59 1.31 1.37
T1 3.11 2.64 3.59 21,970 7057 250 1.62 4.79
T2 1.23 1.09 1.39 12,771 10,388 193 0.744 3.04
(r) Single nucleotide polymorphisms (SNPs) inferred to be introduced by recombination; (m) de novo mutations; (n) samples in the lineage; (ILHR) in-
lineage homoplasy rate; (OLHR) out-of-lineage homoplasy rate.
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related to those of Chlamydia muridarum and Chlamydia suis (Fig.
5B). The pattern of divergence from the reconstructed ancestor is
not uniformamong the clades,whichmaybedue todiffering selec-
tion pressures. Indeed, we found two regions in the C. trachomatis
ompAcladeβ that aremore closely related toancestralC. suis isolates
than other C. trachomatis clades (Supplemental Fig. S6).
No evidence for antimicrobial resistance in circulating
C. trachomatis populations
While chlamydial persistence is a reported but poorly understood
phenomenon (Hogan et al. 2004), there is no evidence for stable
antimicrobial resistance in a clinical setting (Sandoz and Rockey
2010). This is despite the ease at which mutations conferring a
high level antimicrobial resistance to most clinically relevant anti-
microbials can be generated in vitro (for review, see Sandoz and
Rockey 2010) and sporadic reports of clinical resistance (Hogan
et al. 2004; Sandoz and Rockey 2010), including a case of pheno-
typic but not genotypic resistance (O’Neill et al. 2013). Although
none of the isolates in this study were deemed clinically resistant,
in order to understand whether any of these mutations were pre-
sent in a circulating population, we performed a systematic search
for known resistance alleles, either fixed or heterozygous. We
found absolutely no evidence for genomic resistance in this large,
clinically relevant data set. This analysis included the 23S rRNA
gene, which contains previously described resistance mutations
to themacrolide azithromycin, the current frontline antimicrobial
treatment. It is important to note that these sampleswere collected
from patients for routine diagnosis prior to antibiotic treatment
and were not from treatment failures.
Discussion
It is unlikely that older ormore diverse strains will ever be available
for analysis on the scale presented here. Despite the geographical
clustering present in the data, our sampled locations are spread
across the phylogeny, giving us the necessary platform to
draw broad conclusions about the current genomic picture of
this pathogen, such that observations made here about the evolu-
tion of these lineages are likely to be applicable to the species as a
whole.
Our data indicate two distinct phases in the evolution of C.
trachomatis: deep variation and contemporary mixing. The phy-
logeny clearly shows four deeply divergent lineages that we esti-
mate to have expanded over the last few thousand years, with
the flatter appearance of lineage T1 potentially a signature of a
more recent history of clonal expansions than found in T2
(Grenfell 2004). This overall structure is consistent with popula-
tion bottlenecks such as isolation due to barriers created by geo-
graphical isolation facilitated by low host population density
and lack of migration, which create barriers to recombination
flow between groups (Fraser et al. 2007). We speculate that these
populations would diverge, but themselves remain coherent
through periodic selection by recombination and selective sweeps
within the ecotype (Cohan 2001; Bendall et al. 2016). There is no
evidence or requirement under this model for these lineages to be
the result of introgression from other hosts; however, broader
sampling, including of different host species, is required to truly
clarify this hypothesis. Our analyses are not able to address the
possibility of recombination between extant and unsampled
lineages.
Contemporarily, we see large amounts of mixing between
and within lineages. The lower rate of recombination between
LGV and other lineages could be explained by a lower rate of coin-
fection, and therefore opportunity to recombine, with isolates
from other lineages. Detectable recombination in this pathogen
requires coinfection between diverse strains, and we hypothesize
that this has become more frequent due to increases in human
population density andmixing. We speculate that over time these
recombinations will break down the deep phylogenetic structure
Figure 3. Clustering of genes by recombination frequency in each lineage reveals lineage-specific profiles. Each horizontal line represents a gene with
colors corresponding to standard deviations from the clade-specific mean. (Right) Expansion of the seven most actively recombining clusters. Clusters do
not necessarily represent order of genes along the genome.
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we currently observe. While we see recent small-scale expansions
in the phylogeny that correlatewith source location and genotype,
we expect each of these to be transient in nature and, in time, to
disappear as these clades expand and are subject to recombination
with strains outside their niche.
There are three notable exceptions to these trends. The epide-
miologically driven expansion of the L2b monophyly is most
probably due to their epidemiological association to the popula-
tion of men who have sex with men. Thus, this expansion is a
direct result of a niche created by human behavior, as observed
in other pathogens such as Shigella flexneri serotype 3a (Baker
et al. 2015). Second, ocular disease is today mostly understood in
the context of the ocular lineage, which has maintained genetic
coherence potentially due to geographical factors. Recent results
(Andersson et al. 2016), included here, indicate that the trachoma
lineage is not the only source for ocular disease and that this dis-
ease may be more ancient and genetically diverse than the ocular
lineage alone. Finally, the expansion of
genotype E, currently the most prevalent
genotype, may be due to increased fit-
ness at or around ompA, preventing
recombinations being fixed in this
region, being simply a stochastic in-
crease, or being a combination of the
two. These exceptions are fascinating
and reinforce the fact that the evolution-
ary dynamics of C. trachomatis are inter-
twined with human behavior and
population structure.
We noted across all our metrics that
many of the variable regions are focused
around membrane proteins (omp, pmp,
inc), which are believed to be targets of
immune response. We know that differ-
ent lineages often inhabit different nich-
es, and we have for the first time
identified the differing signatures be-
tween lineages that are most likely due
to changing tropic or immune pressures
across the species. These results provide
an invaluable resource for prospective
in vitro studies or for the selection of ap-
propriate vaccine candidates.
At a time in which nearly every hu-
man pathogen is becoming resistant to
antimicrobials, C. trachomatis stands
apart. It is interesting to contrast this
with N. gonorrhoeae, with which it fre-
quently coinfects, which is becoming a
global health concern due to acquired ge-
netic resistance. Our finding that there is
absolutely no genetic evidence of resis-
tance in circulating C. trachomatis is sur-
prising given that resistance can easily
evolve in vitro and that sporadic treat-
ment failures do occur.While the sample
collection did not include treatment fail-
ures, prior exposure to antibiotics (for
any reason) of patients who visited an
STI clinic for either C. trachomatis or N.
gonorrhoeae has been reported to be
∼10% (Dukers-Muijrers et al. 2014).
Thus, although these findings do not preclude the evolution of re-
sistance in clinical cases, they show that any such mutations are
not in the circulating C. trachomatis clinical population sampled
in this study.
If reported treatment failures are a result of genetic muta-
tions, these have not spread, implying that the fitness burden
of resistance is too high for successful transmission. The rapid
rise of the Swedish new variant of C. trachomatis (nvCt) (Seth-
Smith et al. 2009; Unemo et al. 2010; Unemo and Clarke
2011), in which a deletion in the plasmid allowed diagnostic es-
cape, shows that minority variants can rise in frequency to be-
come fixed within a host and that given the right selective
conditions, such as treatment escape, variants can quickly spread
throughout the population. Given that this pathogen has been
one of the two most common bacterial STIs during the entire an-
timicrobial era, the likelihood of resistance emerging and spread-
ing now seems low.
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Figure 4. (A) Temporal analysis of the LGV clade indicates a most recent common ancestor (MRCA)
between 200 CE and 1430 CE (95% highest posterior density [HPD]). Dates along the x-axis are in years
(CE), and blue bars show the 95% posterior probability. Posterior probabilities of node positions are in-
dicated by closed circles (P = 1) or open circles (P > 0.8). (B) The Chlamydia trachomatis LGVmutation rate
is shown in the context of other viruses, bacteria and eukaryotes. Error bars differ per species according to
methodology, but for the case of C. trachomatis represent 95% posterior probability. Data sources shown
in Supplemental Table S3. Buchnera aphidicola, another intracellular bacterium, has a similar genome size
and mutation rate.
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Methods
C. trachomatis strains and DNA extraction
Samples (n = 563) were collected from 21 countries and include
historical and current samples spanning over 50 yr (1957–2012).
Previously published sequences, as well as resequenced strains,
were also included in the analysis. DNA for sequencing was isolat-
ed directly from clinical swabs, from cultured collections, as well as
from historical isolates propagated in yolk sac of embryonated
hens’ eggs. DNAwas processed using a variety of methods, includ-
ing IMS (using an antibody against C. trachomatis lipopolysaccha-
ride) with or without MDA (Seth-Smith et al. 2013a), as well as a
custom SureSelect enrichment system similar to that recently de-
scribed by Christiansen et al. (2014) that allows sequencing from
clinical swabs stored in lysis buffer. Details of all strains and meth-
ods used are in Supplemental Table S1.
Sequencing, mapping, and quality control
Sequencing was performed using Illumina HiSeq with multiplex-
ing using paired read lengths of between 75 and 100 bp. In order
to check coverage and quality, sequences were first mapped to a
published reference chromosome specific to their lineage (T1: F/
SW4, T2: D/UW3, LGV: L2/434, ocular: A/HAR-13) (for accession
numbers, see Supplemental Table S1) using SMALT (version
0.7.4, 90% minimum read identity; www.sanger.ac.uk/resources/
software/smalt/) and GATK insertion/deletion realignment
(McKenna et al. 2010). Sequences with less than 5×mean coverage
across 95% of the chromosome were excluded, as were sequences
with uneven coverage, indicated by a coefficient of variation
greater than one (Seth-Smith et al. 2013b). SNPs were called using
previously described methods (Harris et al. 2012), and short inser-
tions/deletions were included in the resulting alignment. To iden-
tify samples with mixed C. trachomatis populations, we identified
heterozygous sequences by identifying all positions with minor
allele frequencies >0.2 as determined by BCFtools v0.1.19 (Li
et al. 2009; http://samtools.github.io/bcftools/) and excluding
those sequences with more than 300 such positions (mean 105
bp; standard deviation 600 bp). For consistent analysis, we created
a pseudogenome to represent all the diversity observed in a previ-
ously published species-wide analysis (Harris et al. 2012) with gene
names as per the publishedD/UW3 strain (Stephens et al. 1998), to
which all samples were remapped.
Genotyping
Wegenotyped samples bymapping reads to a panel of 28 reference
ompA sequences chosen to represent all previously published ge-
notypes. Genotypes B/Ba, I/Ia, and J/Ja are grouped together since
the ompA sequence differences between these pairs of genotypes
are minimal. Samples were mapped against this panel using the
same parameters given in the previous section. Genotypes were al-
located by minimizing pairwise differences. Where multiple refer-
ences had fewer than two SNPs against the samples, the results
weremanually checked usingArtemis (Carver et al. 2012) to ensure
accurate mapping.
Figure 5. Diversity of the major outer membrane protein (MOMP) gene ompA. (A) Phylogenetic relationship between all 563 Chlamydia trachomatis iso-
lates (ompA gene) shows separation into three clades labeled α, β, and γ. (B) Phylogenetic tree of 1003 MOMP-encoding genes across the Chlamydiaceae.
(C) Divergence (proportion of differing nucleotides) of the ompA gene in three C. trachomatis clades compared with that of a reconstructed ancestor, shad-
ing indicates 10th and 90th percentiles.
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Phylogenetics and recombination detection
Initial chromosome and plasmid phylogenies were constructed us-
ing RAxML (Stamatakis et al. 2005) from a variable sites alignment
using C. muridarum as an outgroup (this outgroup is not displayed
in figures). Putative recombination regions were identified as pre-
viously published (Croucher et al. 2011). In brief, regions of in-
creased SNP density relative to the phylogenetic neighbors were
identified and removed in an iterative fashion. Final phylogenies
were constructed usingRAxMLon the resulting (recombination re-
moved) alignment.
Pairwise sharing of traits was investigated by calculating the
proportion of pairs of isolates below a certain distance (patristic
distance from the recombination removed tree) that share the
same trait. One hundred permutations of the traits were computed
to test the null hypothesis that the trait was not correlatedwith dif-
ference and to calculate the statistical significance of any observed
difference.
Recombination analysis
To investigate the genes affected by recombination and the differ-
ences between lineages, we scored each gene with the number of
recombination events overlapping that gene in each lineage. To
correct for any sampling differences, scores in each lineage were
represented by the number of standard deviations from the
mean (of the lineage). k-means clustering was used to partition
all genes into groups with the number of groups chosen by in-
specting the sum of squared error plot. To explore whether recom-
bination was due to donors from the same lineage, we classed
homoplasic SNPs as those confined to a certain lineage as opposed
to those found inmultiple lineages. The number of such positions
were scaled by the synapomorphic SNPs in a 10-kb slidingwindow
at 1-kb intervals across the genome, similar to the method previ-
ously described (Everitt et al. 2014).
Dating analysis
Only samples with associated sample collection dates were includ-
ed in this analysis with putative recombination events removed
from the genomic data. Root-to-tip regression analysis was used
to date the phylogeny. The significance of this regression was esti-
mated by comparison of the R2 values between 100 permutations.
BEAST version 1.8.0 (Drummond and Rambaut 2007) was run in
triplicate under a strict clock and a number of population models
(constant population size, exponential growth, and Bayesian sky-
line with four groups). In all three cases, the triplicates converged
(effective sample size > 200 and highly similar parameter estimate
distributions), and the inferred tree height andmutation rateswere
comparable.
MOMP comparisons
In addition to the C. trachomatis ompA sequences, 440 genes >500
bp were extracted from NCBI via the search term (“Chlamydia/
Chlamydophila group”[Organism] NOT “Chlamydia trachoma-
tis”[Organism]) AND (ompA[Gene Name] OR MOMP[Gene
Name]). MUSCLE version 3.8.31 (Edgar 2004) was used to align
these genes, and a phylogenetic tree was drawn as before.
Pairwise differences were calculated by comparison with a given
reference and used a 50-bp sliding window with 1-bp step size.
FastML (Pupko et al. 2000) was used to reconstruct theC. trachoma-
tis ancestor.
Putative resistance mutations and 23S rRNA mapping
The high depth of sequence coverage obtained allows identifica-
tion of allele variants that are present but not fixed (as SNPs) in
samples. Short-read mapping data were investigated at positions
that confer antimicrobial resistance in vitro in the literature.
Heterozygous alleles were identified as positions with multiple al-
leles each with a per-strand read depth above five where mapping
and base (phred) quality was above 30, and optical duplicates were
removed. As the reference C. trachomatis genome has two (identi-
cal) copies of the rRNA operon, one copy of the 23S rRNA gene
was masked out during mapping. Kraken (Wood and Salzberg
2014) analysis of readsmapping to this region indicated that a pro-
portion were from other species. We therefore employed differen-
tial mapping to one copy of the C. trachomatis rRNA operon and
the corresponding operon from Lactobacillus salivarius strain
UCC118 (the highest species match frommultiple Kraken results)
and additionally required that mapped reads were properly paired
(i.e., both reads map to the operon). Differential mapping is essen-
tial as DNA from other species is often extracted and subsequently
sequenced at low depth. Due to the high similarity of rRNA re-
gions, this may cause the appearance of heterozygous SNPs and
possible resistance alleles (Supplemental Fig. S7).
Data access
The sequencing data from this study have been submitted to the
European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena)
under the accession numbers listed in Supplemental Table S1.
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